TY - JOUR
T1 - A pilot study exploring the use of hyaluronic acid in treating insertional achilles tendinopathy
AU - Ohana, Nissim
AU - Segal, David
AU - Kots, Eugene
AU - Feldman, Viktor
AU - Nyska, Meir
AU - Palmanovich, Ezequiel
AU - Slevin, Omer
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Purpose: This study explores the use of ultrasound-guided Hyaluronic Acid (HA) injections for Insertional Achilles Tendinopathy (IAT). Methods: A cohort of 15 ankles diagnosed with IAT received three weekly ultrasound-guided HA injections. The Victorian Institute of Sport Assessment – Achilles (VISA-A) questionnaire scored the severity of symptoms and functional impairment before treatment, and at one and six months post-treatment. Results: Significant improvement was observed in VISA-A scores post-treatment, rising from an average baseline of 34.8 ± 15.2 (11-63) to 53.6 ± 20.9 (15-77) after one month, and then to 50.7 ± 18.6 (20-75) after six months. No adverse reactions were noted, underscoring the safety of the intervention. Conclusion: The pilot study presents HA injections as a potentially effective treatment for IAT, while interpretation of these findings must take into account the variability in results, indicating a range of patient responses. It encourages further research to confirm these findings and to explore HA’s full potential in managing IAT, despite the limitations of a small sample size and lack of control group.
AB - Purpose: This study explores the use of ultrasound-guided Hyaluronic Acid (HA) injections for Insertional Achilles Tendinopathy (IAT). Methods: A cohort of 15 ankles diagnosed with IAT received three weekly ultrasound-guided HA injections. The Victorian Institute of Sport Assessment – Achilles (VISA-A) questionnaire scored the severity of symptoms and functional impairment before treatment, and at one and six months post-treatment. Results: Significant improvement was observed in VISA-A scores post-treatment, rising from an average baseline of 34.8 ± 15.2 (11-63) to 53.6 ± 20.9 (15-77) after one month, and then to 50.7 ± 18.6 (20-75) after six months. No adverse reactions were noted, underscoring the safety of the intervention. Conclusion: The pilot study presents HA injections as a potentially effective treatment for IAT, while interpretation of these findings must take into account the variability in results, indicating a range of patient responses. It encourages further research to confirm these findings and to explore HA’s full potential in managing IAT, despite the limitations of a small sample size and lack of control group.
KW - achilles tendinopathy
KW - chronic pain management
KW - functional improvement
KW - heel pain
KW - hyaluronic acid
KW - injection therapies
KW - musculoskeletal injections
KW - non-surgical intervention
KW - pilot study
KW - ultrasound therapy
UR - http://www.scopus.com/inward/record.url?scp=85190338132&partnerID=8YFLogxK
U2 - 10.1177/10225536241242086
DO - 10.1177/10225536241242086
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38589277
AN - SCOPUS:85190338132
SN - 1022-5536
VL - 32
JO - Journal of Orthopaedic Surgery
JF - Journal of Orthopaedic Surgery
IS - 1
ER -